Thermo Fisher Scientific has signed an agreement for the acquisition of Sanofi’s steriles manufacturing site in Ridgefield, New Jersey, US.

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of their strategic partnership with Sanofi to ena ...

Thermo Fisher’s second quarter saw a positive market response, as the company surpassed Wall Street’s revenue and adjusted ...

Thermo Fisher Scientific is expanding its partnership with Sanofi to enable additional U.S. drug-product manufacturing. Under the expanded partnership, Thermo Fisher will acquire Sanofi's sterile ...

The transaction is expected to close in the second half of 2025. MARKET REACTION Shares of Paris-based Sanofi were up 1%, while Thermo Fisher's shares climbed marginally in early trade. KEY QUOTE (S) ...

On July 16, Thermo Fisher Scientific Inc. (NYSE:TMO) announced plans to strategically expand its partnership with Sanofi to support additional drug product manufacturing in the United States.

Thermo Fisher on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its products and services used for developing therapies. Shares of the medical ...

Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported second-quarter 2025 adjusted earnings of $5.36 per share, ...

Manufacturing Thermo Fisher bolsters US fill-finish capacity with Sanofi plant purchase By Kevin Dunleavy Jul 16, 2025 10:49am Thermo Fisher Sanofi Thermo Fisher Scientific biomanufacturing ...

Under the agreement, Thermo Fisher will acquire Sanofi’s steriles manufacturing site in Ridgefield, New Jersey and will continue to manufacture a portfolio of therapies for Sanofi. In addition ...